First, as conveniently evidenced by the authors, not all the diagnosis of CAP were radiologically confirmed, thus probably biasing the results. Moreover, two out of the six allowable signs/symptoms for a clinical diagnosis of pneumonia were more easily applicable in adult than in paediatric patients; these were local chest pain on deep inhalation and increased vocal resonance. Symptoms described in adults with bacterial pneumonia may be noted in older children but are rarely observed in infants and young children [2] . On the contrary, abdominal pain, which is common in lower lobe pneumonia [2] and tachypnea, which, even if recently criticised, remains the most consistent clinical manifestation of paediatric pneumonia above all in developing countries [2, 3] , are not mentioned. Any aetiological analysis has been performed in the study material and exclusion criteria have not been clearly stated. In fact, children who suffer from underlying chronic disease (e.g. sickle cell disease, bronchopulmonary dysplasia, gastro-oesophageal reflux, asthma, cystic fibrosis, congenital heart diseases, immunodeficiency syndromes, neuromuscular diseases and seizure disorders) are at higher risk for acquiring pneumonia [4] . However, among the inclusion criteria the authors included non-Western minorities [1] but not the definite risk factors for CAP (among which are malnutrition, low birth weight and measles immunisation) typical in developing countries and which explain the higher incidence found in these countries [5] . In developing countries pneumonia is not only more common than in Europe and North America, but is also more severe and characterised by a higher mortality rate in the paediatric population [5] .
Secondly, the authors found that lower age is as an independent determinant of CAP in the paediatric population [1] , but this practical aspect has probably not been stressed and discussed enough. Even if the sample size was limited, the data of TEEPE et al. [1] are useful to remark that incidence of pneumonia decreases when children grow up. The incidence of CAP in Finnish children studied during 1981-1982 was 36 out of 1,000 per yr in children aged ,5 yrs and ,16 out of 1,000 per yr in the 5-14 yr age group. A strong male prevalence was found below 5 yrs of age (11.2 out of 1,000 among males and 5.7 out of 1,000 among females) [6] , contrary to the figure found by TEEPE et al. [1] . These estimates were similar in the American paediatric population (1,483 CAP episodes studied between 1964 and 1975): 40 cases out of 1,000 per yr in the 6 months to 5 yrs age group; 22 cases out of 1,000 per yr in children aged 5-9 yrs; 11 cases out of 1,000 per yr in children aged 9-12 yrs; and seven cases out of 1,000 per yr in children aged 12-15 yrs [7] .
Finally, the authors concluded that their study is the first to explore the determinants of CAP in children and young adults in primary care [1] . Actually, the first case-control study on risk factors for paediatric CAP in developed countries is a Finnish study of 201 patients and 250 healthy controls in which HEISKANEN-KOSMA et al. [8] found that children who are prone to recurrent respiratory infections (RRIs), wheezing and acute otitis media are also prone to pneumonia. In this study by HEISKANEN-KOSMA et al. [8] the risk factors for CAP in children aged ,5 yrs were RRIs during the previous 12 months (OR 5.5) and a history of wheezing episodes (OR 5.3) or otitis media treated by tympanocentesis in the first 2 yrs of life (OR 3.6). In the 5-15 yrs age group, risk factors for CAP were RRIs in the last year (OR 3.0) and a positive history for wheezing episodes (OR 2.1) [8] . Significantly, all these findings are in line with the study of TEEPE et al. [1] .
In conclusion, more prospective case-control studies on risk factors for CAP in children are needed to allow us to plan the best prevention strategies. Such studies should cover more epidemiological seasons and they should be based on a proper sample size, radiologically confirmed diagnosis of pneumonia and an extensive microbiological work-up in both hospitalised and ambulatory patients of all paediatric age groups. 
